Selpercatinib (LOXO-292) in patients (pts) with RET-altered thyroid cancer Meeting Abstract
| Authors: | Wirth, L. J.; Sherman, E. J.; Robinson, B.; Solomon, B.; Kang, H.; Lorch, J. H.; Worden, F.; Brose, M. S.; Leboulleux, S.; Godbert, Y.; Meurer, M.; Morris, J.; Owonikoko, T. K.; Tan, D. S. W.; Gautschi, O.; Patel, J.; Yang, L.; Kherani, J.; Cabanillas, M. E.; Shah, M. H. |
| Abstract Title: | Selpercatinib (LOXO-292) in patients (pts) with RET-altered thyroid cancer |
| Meeting Title: | 2021 Annual Meeting of the Japanese Society of Medical Oncology (JSMO) |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2021 Feb 18-21 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-07-01 |
| Start Page: | S289 |
| Language: | English |
| ACCESSION: | WOS:000683609100122 |
| DOI: | 10.1016/j.annonc.2021.05.535 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: O10-3 -- Source: Wos |
